These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38546840)

  • 1. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
    De Silva DTN; Petrovski M; Strunk T; Mukadam N; Page-Sharp M; Moore BR; Batty KT
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1079-1087. PubMed ID: 38546840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings.
    De Silva DTN; Strunk T; Petrovski M; Page-Sharp M; Moore BR; Batty KT
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings.
    Senarathna SMDKG; Strunk T; Petrovski M; Woodland S; Martinez J; Chuang VTG; Batty KT
    Eur J Hosp Pharm; 2023 Oct; ():. PubMed ID: 37875283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
    De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
    Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
    Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
    World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
    Holt RJ; Siegert SW; Krishna A
    J Pediatr Pharmacol Ther; 2008 Jul; 13(3):156-61. PubMed ID: 23055876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Compatibility of Alprostadil with Commonly Used IV Solutions and Medications in the Neonatal Intensive Care Unit.
    Dice JE
    J Pediatr Pharmacol Ther; 2006 Oct; 11(4):233-6. PubMed ID: 23115539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care.
    Koller AK; Krebs S; Dörje F
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three components.
    Nilsson N; Storesund I; Tho I; Nezvalova-Henriksen K
    Eur J Pediatr; 2022 Jul; 181(7):2685-2693. PubMed ID: 35422115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
    Lu J; Liu Q; Kupiec TC; Vail H; Lynch LR; Fam DS; Vu NT
    Int J Pharm Compd; 2021; 25(1):52-61. PubMed ID: 33503010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
    AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F
    Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
    LaPlante KL; Woodmansee S; Mermel LA
    Am J Health Syst Pharm; 2012 Aug; 69(16):1405-9. PubMed ID: 22855107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
    Katip W
    Am J Health Syst Pharm; 2017 Jul; 74(14):1099-1102. PubMed ID: 28687555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates.
    Salamat-Miller N; Qu W; Chadwick JS; McPherson C; Salinas PA; Turner M; Wang D; Barton N
    J Pharm Sci; 2022 May; 111(5):1486-1496. PubMed ID: 34717953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.